Alexandria Phan, MD
Medical Oncology · Milwaukee, WINPI 1821016148
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $174,229 of the $259,650 with a category attached, or 67.1%. Ipsen Biopharmaceuticals, Inc accounts for 72.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $114,378 and has fallen 64.3% since, to $40,856 in 2025. Among medical oncology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 205 payments — averaging $1266.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ipsen Biopharmaceuticals, Inc$188K
- AstraZeneca$27K
- Roche Molecular Systems, Inc.$17K
- Merck$9K
- Exelixis Inc.$8K
- Roche Diagnostics Corporation$5K
- plus $7K from 4 others
Across 67 payments — averaging $8729.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aadi Bioscience, Inc.$547K
- Clovis Oncology, Inc.$23K
- Ipsen Bioscience Inc.$14K
- Pfizer$19
What the payments were for
- Consulting fees$38,87015%
- Speaking & faculty fees$174,22967%
- Travel & lodging$40,82116%
- Food & beverage$5,7302%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 131 | $187,909 |
| AstraZeneca | 18 | $26,822 |
| Roche Molecular Systems, Inc. | 7 | $17,000 |
| Merck | 8 | $8,586 |
| Exelixis Inc. | 18 | $7,528 |
| Roche Diagnostics Corporation | 16 | $5,065 |
| Lexicon Pharmaceuticals, Inc. | 4 | $4,570 |
| Sun Pharmaceutical Industries Inc. | 1 | $1,260 |
| Aadi Bioscience, Inc. | 1 | $850 |
| Fisher & Paykel Healthcare Inc | 1 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ONIVYDE$112,460
- SOMATULINE DEPOT$77,502
- DIAGNOSTICS INFORMATION SYSTEMS$9,000
- Cabometyx$6,801
- Xermelo$4,570
- DIS Navify Software$4,286
- IMFINZI$3,250
- BYNFEZIA PEN$1,260
- FYARRO$850
- RDI Research$571
How this compares
$259,650 in reported general payments places this provider in the 95th percentile of 54 medical oncology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 40 | $1,437 |
| Famotidine | 14 | $219 |
| Prochlorperazine Maleate | 12 | $189 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 12 | $156 |
| Dexamethasone | 12 | $128 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Milwaukee
- Hui-Zi ChenMilwaukee$41K
- Sumana DevataMilwaukee$296
- Stuart WongMilwaukee$33
- Zachary GraffMilwaukee$27
- Paul RitchMilwaukee$26
- Joshua LangMadison$114K
- Dustin DemingMadison$100K
- Kari WisinskiMadison$43K
- Justine BruceMadison$25K
- Francis CuevasFranklin$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.